Signs and symptoms
Genes
Methods
Disclaimer
About us
Publications
Contact us
Patients
Users
Database
Login
Overview of included studies for PARK-FBXO7:
Click here for summary of patients' characteristics
Click here to show world map of all countries
Filter for
all included patients
index patients only
AAO < 50 (adjustable)
AAO >= 50 (adjustable)
females only
males only
homozygous only
heterozygous only
compound heterozygous only
homozygous and compound heterozygous
carrying
definitely pathogenic mutations
probably pathogenic mutations
possibly pathogenic mutations
c.101T>G
c.1132C>G
c.1144+1G>T
c.1408G>T
c.1492C>T
c.152A>G
c.65C>T
Country
China
Iran
Italy
Netherlands
Pakistan
Turkey
Study
Study design
N cases
Ethnicities
Sex
(%
♂
)
Mean AAO (+/- SD)
Reported mutations
Wei, 2018
Other/Mixed
1
n.a.
100%
16
p.Glu470*
+
p.Asn51Ser
: comp. het.
Conedera, 2016
Other/Mixed
1
n.a.
0%
17
p.Arg498*
: hom
Lohmann, 2015
Family study
2
n.a.
50%
47(+/-8)
p.Leu34Arg
: hom
Gündüz, 2014
Family study
2
n.a.
50%
14(+/-2)
p.Arg498*
: hom
Yalcin-Cakmakli, 2014
Family study
2
n.a.
50%
12(+/-3)
p.Arg498*
: hom
Paisán-Ruiz, 2010
Other/Mixed
4
n.a.
25%
20(+/-4)
p.Arg498*
: hom
Di Fonzo, 2009
Family study
4
C
50%
15(+/-4)
p.Thr22Met
+
c.1144+1G>T
: comp. het.
p.Arg498*
: hom
Shojaee, 2008
Other/Mixed
10
n.a.
80%
20
p.Arg378Gly
: hom
© University of Lübeck. Last updated on
Dec. 2, 2020. Version: 3.5.95
MDSGene works best with JavaScript enabled. Please follow
these instructions
to activate JavaScript in your web browser.
MDSGene works best with JavaScript enabled. Please follow
these instructions
to activate JavaScript in your web browser.